Molnupiravir Cuts Risk for Severe COVID-19 Illness in Adults
Risk for hospitalization or death lower in at-risk adults with mild-to-moderate COVID-19 receiving oral therapy with molnupiravir versus placebo
Factors ID’d for Severe GI Effects of SARS-CoV-2 in Children
Among children infected with SARS-CoV-2, 9.5 percent have severe GI effects, such as disseminated adenomesenteritis, appendicitis, pancreatitis
Family Impact of Child With Life-Threatening Illness Examined
Family members of children with a serious pediatric illness have higher rates of health care encounters, diagnoses, prescriptions
Flu Vaccine May Not Protect Against Main Flu Strain
However, vaccine still likely to protect against severe illness and death
FDA Allows Abortion Pill to Stay Available by Mail
After a telemedicine appointment with a provider, patients can receive medication via the mail
Biden Administration to Tackle Lead in Drinking Water
New, tougher limits to be imposed by the EPA are expected to be finalized by 2024
Pfizer Vaccine Disappoints in Children Ages 2 to 5 Years
Pfizer-BioNTech will try a third dose to see if it produces a more robust response
Severe Mental Illness Tied to Poorer COVID-19 Outcomes
Findings seen for COVID-19 infection, hospitalization, and mortality
Physician’s Briefing Weekly Coronavirus Roundup
Reemergent RSV Epidemics Could Be More Intense in 2021 to 2022
Virus introduced from external sources linked to emergence of spring and summer epidemic in 2021
